In animal models, BPC-157 has been associated with faster tendon healing , reduced inflammation, and stronger repaired tissue
They are approved for people who are obese or overweight and have at least one health issue related to weight, such as high blood pressure or Type 2 diabetes
GLP-1RAs as a support for MCAS For some basics: glucagon-like peptide-1 receptor agonists (abbreviated as GLP-1 medications or as I noted above, GLP-1RAs) are a class of medications that includes semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound, which also work on GIP receptors), as well as in-trials Retatrutide (a triple agonist that works on GLP-1, GIP, and Glucagon receptors)
Furthermore, increased mucosal permeability in UC exposes the immune system to bacterial antigens, leading to abnormal immune responses that exacerbate inflammation and disrupt immune regulation